Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy

MLA

Adrian Fairey, et al. “Clinical Analysis of EV‐Fingerprint to Predict Grade Group 3 and above Prostate Cancer and Avoid Prostate Biopsy.” Cancer Medicine, vol. 12, no. 15, Aug. 2023, pp. 15797–808. EBSCOhost, https://doi.org/10.1002/cam4.6216.

APA

Adrian Fairey, Robert J. Paproski, Desmond Pink, Deborah L. Sosnowski, Catalina Vasquez, Bryan Donnelly, Eric Hyndman, Armen Aprikian, Adam Kinnaird, Perrin H. Beatty, & John D. Lewis. (2023). Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy. Cancer Medicine, 12(15), 15797–15808. https://doi.org/10.1002/cam4.6216

Chicago

Adrian Fairey, Robert J. Paproski, Desmond Pink, Deborah L. Sosnowski, Catalina Vasquez, Bryan Donnelly, Eric Hyndman, et al. 2023. “Clinical Analysis of EV‐Fingerprint to Predict Grade Group 3 and above Prostate Cancer and Avoid Prostate Biopsy.” Cancer Medicine 12 (15): 15797–808. doi:10.1002/cam4.6216.